Literature DB >> 11059925

Portal-systemic encephalopathy in non-cirrhotic patients: classification of clinical types, diagnosis and treatment.

A Watanabe1.   

Abstract

Hepatic encephalopathy is suspected in non-cirrhotic cases of encephalopathy because the symptoms are accompanied by hyperammonaemia. However, the cause of the large portal-systemic shunt formation observed in these cases is not clear, as cirrhosis and portal hypertension are absent. The frequency of such cases reported in the literature is increasing with progress and spread of abdominal imaging diagnostic techniques. Some cases have been misdiagnosed as psychiatric diseases (dementia, depression and others) and consequently patients have been hospitalized in psychiatric institutions or geriatric facilities. Some paediatric cases have also been misdiagnosed. Therefore, the importance of accurate diagnosis of this disease should be strongly emphasized. Some paediatric cases have also been misdiagnosed. When psychoneurological symptoms are suggestive of hepatic encephalopathy but objective and subjective symptoms or abnormal values of liver function tests are not sufficiently indicative of liver cirrhosis, portal-systemic encephalopathy should be suspected. Abnormal angiograms of the portal vein, superior mesenteric vein or splenic vein are conclusive evidence of portal-systemic encephalopathy. Transrectal portal scintigraphy also provides information useful for detection of shunts and a quantitative estimation of shunt index. We classified the disease into five types based on whether the shunt is formed inside or outside the liver. Type I (intrahepatic type) designates cases in which shunts are located between the portal and systemic veins. Type II designates a type of intra/extrahepatic shunt that originates from the umbilical part of the portal vein and serpentines in the liver, then leaves the liver. Type III (extrahepatic type) occurs most frequently. Type IV (extrahepatic) is accompanied by shunts similar to those in type III, but hepatic pathology presents as idiopathic portal hypertension. Type V (extrahepatic) represents the congenital absence of the portal vein, where the superior mesenteric vein joins the intrahepatic inferior vena cava or the left renal vein. The prevalence of each type in our country was examined by a nationwide investigation. In addition to the conventional diet or drug treatments, obliteration by less invasive interventional radiology using a metallic coil and ethanol has recently been used more frequently than surgical occlusion of shunts. Shunt-preserving disconnection of portal and systemic circulation and partial splenic artery embolization are also performed. International investigation of the disease status and establishment of diagnostic and therapeutic methods for the disease are awaited and investigation of long-term prognosis after therapy is also necessary.

Entities:  

Mesh:

Year:  2000        PMID: 11059925     DOI: 10.1046/j.1440-1746.2000.02283.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  40 in total

Review 1.  Hepatic encephalopathy as a complication of liver disease.

Authors:  S vom Dahl; G Kircheis; D Häussinger
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Relationship between encephalopathy and portal vein-vena cava shunt: value of computed tomography during arterial portography.

Authors:  Qian Chu; Zhen Li; Su-Ming Zhang; Dao-Yu Hu; Ming Xiao
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

3.  Senile portosystemic hepatic encephalopathy as a treatable dementia-like syndrome.

Authors:  Shoichi Ito; Ryuji Sakakibara; Yasumasa Yoshiyama; Takamichi Hattori
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

4.  Portosystemic shunt with polysplenia and hypoplastic left heart syndrome.

Authors:  H Ikeda; H Aotsuka; H Nakajima; M Sawada
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

5.  Successful portal-systemic shunt occlusion of a direct shunt between the inferior mesenteric vein and inferior vena cava with balloon-occluded retrograde transvenous obliteration following recanalization after placing a covered stent in the portal and superior mesenteric veins.

Authors:  Sadao Hayashi; Yasutaka Baba; Terutoshi Senokuchi; Kazuto Ueno; Masayuki Nakajo
Journal:  Jpn J Radiol       Date:  2009-06-06       Impact factor: 2.374

6.  Congenital portosystemic shunts and AMPLATZER vascular plug occlusion in newborns.

Authors:  William N Evans; Alvaro Galindo; Ruben J Acherman; Abraham Rothman; Dean P Berthoty
Journal:  Pediatr Cardiol       Date:  2009-07-23       Impact factor: 1.655

7.  Portal-systemic encephalopathy in a non-cirrhotic patient.

Authors:  K Fukushima; M Kurozumi; M Kadoya; S Ikeda
Journal:  BMJ Case Rep       Date:  2009-02-16

8.  Congenital multiple intrahepatic portosystemic shunt: an autopsy case.

Authors:  Seishiro Takahashi; Eriko Yoshida; Yasushi Sakanishi; Norihiro Tohyama; Ayse Ayhan; Hiroshi Ogawa
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

9.  Portosystemic encephalopathy due to mesoiliac shunt in a patient without cirrhosis.

Authors:  Sobia Ali; Alan H Stolpen; Warren N Schmidt
Journal:  J Clin Gastroenterol       Date:  2010 May-Jun       Impact factor: 3.062

10.  Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy.

Authors:  A Sidney Barritt; Michael W Fried; Paul H Hayashi
Journal:  Dig Dis Sci       Date:  2009-08-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.